SCHEMBL16978652

SCHEMBL16978652

CCOC(=O)c1[nH]c(=O)c(O)c2c1CCN(Cc1ccccc1)C2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
HPGD P15428 3/20 0.47
GAA P10253 1/20 0.47
HSD17B10 Q99714 1/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
CASP3 P42574 1/20 0.45
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
LMNA P02545 3/20 0.42
MAPT P10636 1/20 0.42
ADORA1 P30542 1/20 0.42
BRD4 O60885 1/20 0.41
TRPC5 Q9UL62 1/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16978651 0.86 DDB1 (0.44) ALDH1A1HPGDGAAHSD17B10KMT2A
SCHEMBL4939209 0.85 ALDH1A1 (0.43) ALDH1A1HPGDGAAKMT2AMEN1
SCHEMBL16978678 0.84 PARP1 (0.46) ALDH1A1HPGDGAAHSD17B10KMT2A
SCHEMBL4478189 0.79 LMNA (0.46) ALDH1A1GAAKMT2AMEN1TSHR
SCHEMBL4484069 0.79 MEN1 (0.48) ALDH1A1KMT2AMEN1MAPK1LMNA
SCHEMBL16007931 0.78 BRD4 (0.48) ALDH1A1HPGDGAAKMT2AMEN1
SCHEMBL4488507 0.76 AKR1B1 (0.47) ALDH1A1HPGDKMT2AMEN1MAPK1
SCHEMBL4484368 0.75 MEN1 (0.39) ALDH1A1KMT2AMEN1LMNABRD4
SCHEMBL18920023 0.74 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1CASP3LMNA
SCHEMBL4494967 0.73 POLB (0.46) ALDH1A1HPGDKMT2AMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150218164-A1 SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. 2015-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218164-A1 SUBSTITUTED NAPHTHYRIDINEDIONE DERIVATIVES AS HIV INTEGRASE INHIBITORS SAMHD1, ENTPD5, DUT ALDH1A1 1014/4885HPGD 259/4885GAA 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.